BC Platforms appoints Dr Carolin Bender as Chief Medical Officer
ZURICH, Switzerland, April 03, 2023 (GLOBE NEWSWIRE) — BC Platforms (BCP), a global leader in…
Month: April 2023
BC Platforms appoints Dr Carolin Bender as Chief Medical Officer
ZURICH, Switzerland, April 03, 2023 (GLOBE NEWSWIRE) — BC Platforms (BCP), a global leader in…
aVaxziPen Announces Positive Data in Multiple Diseases on Novel Needle-Free Vaccine, Thermally Stable Delivery Platform at World Vaccine Congress
In vivo data demonstrates immune equivalence to traditional needle and syringe injection when using a…
aVaxziPen Announces Positive Data in Multiple Diseases on Novel Needle-Free Vaccine, Thermally Stable Delivery Platform at World Vaccine Congress
In vivo data demonstrates immune equivalence to traditional needle and syringe injection when using a…
Genomic Vision rejoint France BioLead pour participer au développement et à l’innovation des produits biopharmaceutiques en France
GÉNOMIQUE | THÉRAPIES CELLULAIRES & GÉNÉTIQUES | BIOPRODUCTION Genomic Vision rejoint France BioLead pour participer…
Genomic Vision rejoint France BioLead pour participer au développement et à l’innovation des produits biopharmaceutiques en France
GÉNOMIQUE | THÉRAPIES CELLULAIRES & GÉNÉTIQUES | BIOPRODUCTION Genomic Vision rejoint France BioLead pour participer…
Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
BioSenic appoints Lieven Huysse, MD, as Chief Medical Officer
INSIDE INFORMATION Appointment to drive late-stage clinical development of BioSenic’s cell therapy and autoimmune disease…
BioSenic appoints Lieven Huysse, MD, as Chief Medical Officer
INSIDE INFORMATION Appointment to drive late-stage clinical development of BioSenic’s cell therapy and autoimmune disease…
Addex Raises $5.0 Million in Equity Financing
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 3, 2023 – Addex…
Addex Raises $5.0 Million in Equity Financing
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 3, 2023 – Addex…
Liverpool University Hospitals and Attensi Launch ‘Game-Changer’ Tech to Clamp Down on Fraud
Attensi partnered with LIVERPOOL UNIVERSITY HOSPITALS to LAUNCH ‘GAME-CHANGER’ TECH TO CLAMP DOWN ON FRAUD…
Liverpool University Hospitals and Attensi Launch ‘Game-Changer’ Tech to Clamp Down on Fraud
Attensi partnered with LIVERPOOL UNIVERSITY HOSPITALS to LAUNCH ‘GAME-CHANGER’ TECH TO CLAMP DOWN ON FRAUD…
SCG, Toyota, and CJPT Sign an MOU towards achieving Carbon Neutrality in Thailand
TOKYO, Apr 3, 2023 – (JCN Newswire) – Siam Cement Group (SCG), Toyota Motor Corporation…
SCG, Toyota, and CJPT Sign an MOU towards achieving Carbon Neutrality in Thailand
TOKYO, Apr 3, 2023 – (JCN Newswire) – Siam Cement Group (SCG), Toyota Motor Corporation…
CP, Toyota, and CJPT Sign an MOU towards achieving Carbon Neutrality in Thailand
TOKYO, Apr 3, 2023 – (JCN Newswire) – Charoen Pokphand Group (CP), Toyota Motor Corporation…
CP, Toyota, and CJPT Sign an MOU towards achieving Carbon Neutrality in Thailand
TOKYO, Apr 3, 2023 – (JCN Newswire) – Charoen Pokphand Group (CP), Toyota Motor Corporation…
Eisai Enters Into Agreement With National Cancer Center to Collaborate on Investigator-Initiated Clinical Research for Anticancer Agent Tazemetostat Based on “Patient-Proposed Healthcare Services” System
TOKYO, Apr 3, 2023 – (JCN Newswire) – Eisai Co., Ltd. announced today that it…
Agilent Announces Thought Leader Award to Dr. Chenli Liu
Shenzhen Institute of Advanced Technology researcher recognized for his pioneering work in synthetic biology SANTA…